Basic Information | Post buying leads | Suppliers | Cas Database |
Name |
N-Acetylamphetamine |
EINECS | N/A |
CAS No. | 14383-60-9 | Density | 0.995 g/cm3 |
PSA | 32.59000 | LogP | 2.59400 |
Solubility | N/A | Melting Point |
67 °C |
Formula | C11H15NO | Boiling Point | 349.6 °C at 760 mmHg |
Molecular Weight | 177.246 | Flash Point | 207.3 °C |
Transport Information | N/A | Appearance | N/A |
Safety | Risk Codes | N/A | |
Molecular Structure | Hazard Symbols | N/A | |
Synonyms |
Acetamide,N-(a-methylphenethyl)- (6CI,7CI,8CI);Acetylamphetamine;N-(a-Methylphenethyl)acetamide;N-Acetyl-b-phenylisopropylamine;N-Acetylamphetamine; |
Article Data | 30 |
The IUPAC name of N-Acetylamphetamine is N-(1-phenylpropan-2-yl)acetamide. With the CAS registry number 14383-60-9, it is also named as Acetamide, N-(alpha-methylphenethyl)-. The product's classification code is Drug / Therapeutic Agent. Besides, it is metabolite of Pheniprazine. In addition, its molecular formula is C11H15NO and molecular weight is 177.2429.
The other characteristics of N-Acetylamphetamine can be summarized as: (1)ACD/LogP: 1.47; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): 1.47; (4)ACD/LogD (pH 7.4): 1.47; (5)ACD/BCF (pH 5.5): 7.72; (6)ACD/BCF (pH 7.4): 7.72; (7)ACD/KOC (pH 5.5): 150.26; (8)ACD/KOC (pH 7.4): 150.26; (9)#H bond acceptors: 2; (10)#H bond donors: 1; (11)#Freely Rotating Bonds: 3; (12)Polar Surface Area: 20.31 Å2; (13)Index of Refraction: 1.51; (14)Molar Refractivity: 53.28 cm3; (15)Molar Volume: 178 cm3; (16)Polarizability: 21.12×10-24cm3; (17)Surface Tension: 35.1 dyne/cm; (18)Density: 0.995 g/cm3; (19)Flash Point: 207.3 °C; (20)Enthalpy of Vaporization: 59.41 kJ/mol; (21)Boiling Point: 349.6 °C at 760 mmHg; (22)Vapour Pressure: 4.65E-05 mmHg at 25 °C.
People can use the following data to convert to the molecule structure.
(1)SMILES: O=C(NC(Cc1ccccc1)C)C
(2)InChI: InChI=1/C11H15NO/c1-9(12-10(2)13)8-11-6-4-3-5-7-11/h3-7,9H,8H2,1-2H3,(H,12,13)
(3)InChIKey: YPKBVWZHVTZSPU-UHFFFAOYAA
The toxicity data is as follows:
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
mouse | LD50 | intravenous | 213mg/kg (213mg/kg) | BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY) | Acta Pharmacologica et Toxicologica. Vol. 38, Pg. 474, 1976. |